Evaluation of Non-B Non-C Liver Cirrhosis in A EL-Rajhi Assuit University Hospital: A Retrospective-Prospective Study

Assiut University

Status: Not yet enrolling

Conditions: Non-B Non-C Liver Cirrhosis

Treatments: Diagnostic Test: Diagnostic tests

Study type: Observational

Funder types: Other

Identifiers

NCT05314270

Non-B Non-C Liver cirrhosis

Details and patient eligibility

About

To study the etiologies of patients diagnosed as non-B, non-C liver cirrhosis (NBNC-LC).

To describe the different patient's outcomes.

Full description

Liver cirrhosis is the ultimate fate of many hepatic insults that may be viral, immunologic, and metabolic or even cryptogenic. (Tsochatzis EA et al., 2014)

Recently, Non-Alcoholic Fatty Liver Disease (NAFLD) present a serious health burden worldwide that affects around 25% of the global adult population with a prevalence of around 31.8% in the Middle East. (Younossi ZM, et al., 2019)

Most of Egyptian patients presented with end-stage liver disease are secondary to post-hepatitic cirrhosis is estimated to be more than 80% of cases. (Guerra J et al., 2012)

The real profile of non-B, non-C etiologies of liver cirrhosis, in Egyptian patients, is still not fully evaluated.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All pateints diagnosed as Non-B Non-C Liver Cirrhosis in the period from 2017_2023

Exclusion criteria

• We will exclude the pateints that will be diagnosed as HBV-HCV induced Liver Cirrosis